LIT-001 TFA

More efficient, faster and cheaper. Ace Therapeutics are trustworthy.

sale

LIT-001 TFA

Specification
Cat. No.
SMD453
Related Diseases
Autism
Product Name
LIT-001 TFA
Size
5.0mg; 10.0mg; 25.0mg; 50.0mg; 100.0mg; 200.0mg; Click to view more sizes and prices
Price
Inquiry
Availability
2 Weeks
Description
LIT-001 is the First Nonpeptide Oxytocin Receptor Agonist that Improves Social Interaction in a Mouse Model of Autism.
CAS Number
2245072-21-1 (TFA)
Chemical Formula
C30H34F3N7O4S
Molecular Weight
645.7022
Elemental Analysis
C, 55.80; H, 5.31; F, 8.83; N, 15.18; O, 9.91; S, 4.97
Synonym
LIT-001; LIT 001; LIT001; LIT-001 TFA; LIT-001; LIT001; LIT 001;
IUPAC/Chemical Name
(S)-2-(Dimethylcarbamothioyl)-N-(2-methyl-4-(1-methyl-1,4,5,10-tetrahydrobenzo[b]pyrazolo[3,4-e][1,4]diazepine-5-carbonyl)benzyl)pyrrolidine-1-carboxamide, Trifluoroacetate
InChi Key
BZHSRXWFCSEPQQ-JIDHJSLPSA-N
InChi Code
InChI=1S/C28H33N7O2S.C2HF3O2/c1-18-14-19(11-12-20(18)15-29-28(37)34-13-7-10-24(34)27(38)32(2)3)26(36)35-17-21-16-30-33(4)25(21)31-22-8-5-6-9-23(22)35;3-2(4,5)1(6)7/h5-6,8-9,11-12,14,16,24,31H,7,10,13,15,17H2,1-4H3,(H,29,37);(H,6,7)/t24-;/m0./s1
SMILES Code
O=C(N1[C@H](C(N(C)C)=S)CCC1)NCC2=CC=C(C(N3C4=CC=CC=C4NC(N(C)N=C5)=C5C3)=O)C=C2C.O=C(O)C(F)(F)F
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4℃ for short term (days to weeks), or -20℃ for long term (months).
HS Tariff Code
2934.99.9001
All of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Enter Your Email to Subscribe

Enter your E-mail and receive the latest news from us

Copyright © Ace Therapeutics. All Rights Reserved.
Top